Cancer research
Researchers have been working tirelessly to combat the rising incidence of lung cancer, a leading cause of morbidity and mortality worldwide. Among the various subtypes of lung cancer, non-small cell lung cancer (NSCLC) accounts for approximately 85% of all cases, with a significant proportion of patients still relapsing after undergoing
Cancer research
Men with BRCA1 and BRCA2 gene mutations face a significantly higher risk of aggressive prostate cancer, according to a new study published in the European Society for Medical Oncology (ESMO) Congress in Berlin. The study, funded by Cancer Research UK, the Institute of Cancer Research (ICR), and others, found that
Cancer research
Scientists at The Institute of Cancer Research in London have made a breakthrough discovery in treating advanced prostate cancer. They have found that a combination of two targeted drugs could slow down tumour growth and kill cancer cells in up to two-fifths of patients with this type of cancer. The
Cancer research
Scientists at The Institute of Cancer Research in London have made a breakthrough discovery in treating advanced prostate cancer. They have found that a combination of two targeted drugs could slow down tumour growth and kill cancer cells in up to two-fifths of patients with this type of cancer. The
Cancer research
Researchers at Lund University have made a significant discovery in the fight against cancer, identifying Leucine-Rich Repeat Containing 15 (LRRC15) as a promising biomarker and target for cancer therapy. According to their study, published in Signal Transduction and Targeted Therapy, transforming growth factor-b (TGFb) induces the expression of LRRC15 specifically
Cancer research
Researchers at Gifu University Graduate School of Medicine have made a significant breakthrough in the treatment of prostate cancer, particularly in cases of metastatic castration-sensitive prostate cancer (mCSPC). A recent study published in Cancer Reports has demonstrated the efficacy of a combination therapy involving androgen receptor signaling inhibitors, denosumab, and
Cancer research
A study by the Institute of Cancer Research has found early evidence that combining two existing drugs could be an effective treatment for advanced prostate cancer, potentially benefiting 40% of men with the disease. The researchers discovered that using both drugs in tandem could kill cancer cells and slow tumour
Cancer research
Researchers at the Howard University College of Medicine have presented a case report highlighting the challenges of managing advanced-stage colorectal cancer in the context of the COVID-19 pandemic. The report illustrates the importance of timely colorectal cancer screening and follow-up, particularly among African Americans, who face a disproportionate burden of
Cancer research
La-Urshalar Brock, an Emory University nursing PhD student, has been awarded the Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship from the National Institutes of Health (NIH). This highly competitive award supports promising predoctoral students conducting mentored research that contributes to the nation's health-related research
Cancer research
Researchers in Shanghai have made significant strides in cancer gene therapy by harnessing the power of natural killer (NK) cells. According to a recent study published in Critical Reviews In Oncology Hematology, genetic engineering strategies have been optimized to enhance NK cell antitumor function, offering new hope for cancer treatment.
Cancer research
A recent study published in the journal Nature has shed new light on the mechanisms of T cell exhaustion in cancer patients. Researchers from the Ohio State University Comprehensive Cancer Center-The James found that a non-stochastic pathway-specific discordance between mRNA and protein dynamics in T cells contributes to the development
Cancer research
Researchers have made a breakthrough in cancer treatment with the discovery of lipid nanoparticle-encapsulated mRNA encoding tumor-specific toxin proteins. This innovative approach has shown promising results in reducing tumor growth and activating antitumor immunity, providing a potential solution for treating tumors that are resistant or unresponsive to immunotherapy. According to
